Investors & Media Search: Select: Select Current Company News News archive 2019 News archive 2018 News archive 2017 News archive 2016 News archive 2015 News archive 2014 News archive 2013 News archive 2012 News archive 2011 News archive 2010 News archive 2009 News archive 2008 News archive 2007 News archive 2006 May 13, 2010Recent article about ISCO's Cornea Program May 10, 2010International Stem Cell and Absorption Systems Confirm Results Showing Stem Cell Derived Corneal Tissue as an Alternative to Animals for Drug Testing Apr 13, 2010International Stem Cell Corporation Engages Leading Immunogeneticists to Advance its Industry-first, Immune-matched Stem Cells Apr 08, 2010International Stem Cell Corporation Provides Strategic Update on Its Skin Care Program Mar 31, 2010International Stem Cell (ISCO) Announces the Signing of a Distribution Agreement with Veritas Corporation, Opening Japanese Markets for Its Lifeline Cell Technology® Brand of Human Cell Culture Products Mar 18, 2010International Stem Cell Corporation Begins Its Second Pre-Clinical Phase of Testing Retinal Pigment Epithelium (RPE) Derived from Human Parthenogenetic Stem Cells for Treatment of Retinal Diseases Mar 02, 2010International Stem Cell Corporation Parthenogenetic Stem Cell Line Shown to Carry the Most Common Immune Genes Matched to the U.S. Population Retains Stem Cell Characteristics over Two Years in Culture, Which is Necessary for Therapeutic Value Feb 16, 2010International Stem Cell Corporation Provides Strategic Update on the Company's Cornea Transplantation Program Feb 04, 2010International Stem Cell Corporation Opens Facility for Development and Production of Clinical-Grade Stem Cell Products Jan 28, 2010International Stem Cell Corporation Announces Shareholder Conference Call 21 22 23 24 25 26 27 28 29 30 31 << < > >>